Sonnet BioTherapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeSonnet BioTherapeutics
Sonnet BioTherapeutics logo

Sonnet BioTherapeutics

0 followers

SONN

Performance

About Sonnet BioTherapeutics

Sonnet BioTherapeutics is a biotechnology company developing targeted immuno-oncology drugs using its proprietary FHAB technology to empower innovative targeted biologic drugs.

Recent News

Recent Deals

Key Facts

HQ Location

Princeton, United States

Founded

2015

Employees

11 - 50

Status

Public

Website

https://sonnetbio.com